These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

468 related articles for article (PubMed ID: 27468210)

  • 1. Pleiotropic effects of statins in the diseases of the liver.
    Janicko M; Drazilova S; Pella D; Fedacko J; Jarcuska P
    World J Gastroenterol; 2016 Jul; 22(27):6201-13. PubMed ID: 27468210
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emerging role of statin therapy in the prevention and management of cirrhosis, portal hypertension, and HCC.
    Sharpton SR; Loomba R
    Hepatology; 2023 Dec; 78(6):1896-1906. PubMed ID: 37013380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of addition of statins to antiviral therapy in hepatitis C virus-infected persons: Results from ERCHIVES.
    Butt AA; Yan P; Bonilla H; Abou-Samra AB; Shaikh OS; Simon TG; Chung RT; Rogal SS;
    Hepatology; 2015 Aug; 62(2):365-74. PubMed ID: 25847403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Addition of statins to the standard treatment in patients with cirrhosis: Safety and efficacy.
    Muñoz AE; Pollarsky FD; Marino M; Cartier M; Vázquez H; Salgado P; Romero G
    World J Gastroenterol; 2021 Jul; 27(28):4639-4652. PubMed ID: 34366626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of etiological treatment on prognosis.
    Su CW; Yang YY; Lin HC
    Hepatol Int; 2018 Feb; 12(Suppl 1):56-67. PubMed ID: 28702738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of Statins in Patients with Chronic Liver Disease and Cirrhosis: Current Views and Prospects.
    Vargas JI; Arrese M; Shah VH; Arab JP
    Curr Gastroenterol Rep; 2017 Sep; 19(9):43. PubMed ID: 28752475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SACRED: Effect of simvastatin on hepatic decompensation and death in subjects with high-risk compensated cirrhosis: Statins and Cirrhosis: Reducing Events of Decompensation.
    Kaplan DE; Mehta R; Garcia-Tsao G; Albrecht J; Aytaman A; Baffy G; Bajaj J; Hernaez R; Hunt K; Ioannou G; Johnson K; Kanwal F; Lee TH; Monto A; Pandya P; Schaubel D; Taddei TH
    Contemp Clin Trials; 2021 May; 104():106367. PubMed ID: 33771685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential for statins in the chemoprevention and management of hepatocellular carcinoma.
    Lonardo A; Loria P
    J Gastroenterol Hepatol; 2012 Nov; 27(11):1654-64. PubMed ID: 22849701
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current and future pharmacological therapies for managing cirrhosis and its complications.
    Kockerling D; Nathwani R; Forlano R; Manousou P; Mullish BH; Dhar A
    World J Gastroenterol; 2019 Feb; 25(8):888-908. PubMed ID: 30833797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatic venous pressure gradient and outcomes in cirrhosis.
    Ripoll C
    J Clin Gastroenterol; 2007; 41 Suppl 3():S330-5. PubMed ID: 17975485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Should we continue surveillance for hepatocellular carcinoma and gastroesophageal varices in patients with cirrhosis and cured HCV infection?
    Isfordink CJ; Maan R; de Man RA; van Erpecum KJ; van der Meer AJ
    Eur J Intern Med; 2021 Dec; 94():6-14. PubMed ID: 34563447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of interferon treatment on development and progression of hepatocellular carcinoma in patients with chronic virus infection: a meta-analysis of randomized controlled trials.
    Zhang CH; Xu GL; Jia WD; Li JS; Ma JL; Ge YS
    Int J Cancer; 2011 Sep; 129(5):1254-64. PubMed ID: 21710498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does antiviral therapy prevent hepatocellular carcinoma?
    Kwon H; Lok AS
    Antivir Ther; 2011; 16(6):787-95. PubMed ID: 21900710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Three months of simvastatin therapy vs. placebo for severe portal hypertension in cirrhosis: A randomized controlled trial.
    Pollo-Flores P; Soldan M; Santos UC; Kunz DG; Mattos DE; da Silva AC; Marchiori RC; Rezende GF
    Dig Liver Dis; 2015 Nov; 47(11):957-63. PubMed ID: 26321186
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Strategies for the prevention of hepatocellular carcinoma in the context of chronic viral hepatitis].
    Schott E; Bergk A; Berg T
    Z Gastroenterol; 2008 Jan; 46(1):69-80. PubMed ID: 18188819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Maintenance therapy with peginterferon alfa-2b does not prevent hepatocellular carcinoma in cirrhotic patients with chronic hepatitis C.
    Bruix J; Poynard T; Colombo M; Schiff E; Burak K; Heathcote EJ; Berg T; Poo JL; Mello CB; Guenther R; Niederau C; Terg R; Bedossa P; Boparai N; Griffel LH; Burroughs M; Brass CA; Albrecht JK;
    Gastroenterology; 2011 Jun; 140(7):1990-9. PubMed ID: 21419770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systematic review with a meta-analysis: clinical effects of statins on the reduction of portal hypertension and variceal haemorrhage in cirrhotic patients.
    Wan S; Huang C; Zhu X
    BMJ Open; 2019 Jul; 9(7):e030038. PubMed ID: 31315875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapy. Statins and liver disease: from concern to 'wonder' drugs?
    Bosch J; Forns X
    Nat Rev Gastroenterol Hepatol; 2015 Jun; 12(6):320-1. PubMed ID: 25963509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of antiviral therapy in the prevention of hepatocellular carcinoma.
    Franco J; Saeian K
    J Vasc Interv Radiol; 2002 Sep; 13(9 Pt 2):S191-6. PubMed ID: 12354836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The benefit of statins in chronic hepatitis C patients: a systematic review and meta-analysis.
    Zheng YX; Zhou PC; Zhou RR; Fan XG
    Eur J Gastroenterol Hepatol; 2017 Jul; 29(7):759-766. PubMed ID: 28240613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.